CY1108033T1 - Βελτιωμενη παιδιατρικη συνθεση και μεθοδοι για την παροχη τροφης και τη βελτιωση της ανεκτικοτητος - Google Patents

Βελτιωμενη παιδιατρικη συνθεση και μεθοδοι για την παροχη τροφης και τη βελτιωση της ανεκτικοτητος

Info

Publication number
CY1108033T1
CY1108033T1 CY20061100828T CY061100828T CY1108033T1 CY 1108033 T1 CY1108033 T1 CY 1108033T1 CY 20061100828 T CY20061100828 T CY 20061100828T CY 061100828 T CY061100828 T CY 061100828T CY 1108033 T1 CY1108033 T1 CY 1108033T1
Authority
CY
Cyprus
Prior art keywords
composition
pediatric
methods
nutrition
infertility
Prior art date
Application number
CY20061100828T
Other languages
English (en)
Inventor
Marlene W Borschel
Steven T Luebbers
Cynthia J Black
Daniel L Mckamy
Timothy Costigan
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23980707&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1108033(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of CY1108033T1 publication Critical patent/CY1108033T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/269—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
    • A23L29/27—Xanthan not combined with other microbial gums
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00—Food or edible material: processes, compositions, and products
    • Y10S426/801—Pediatric

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Pediatric Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Η παρούσα εφεύρεση παρέχει μία βελτιωμένη παιδιατρική σύνθεση και μεθόδους παροχής τροφής και αυξήσεως της ανεκτικότητος σε παιδιατρικούς ασθενείς. Η σύνθεση μπορεί να παρέχεται υπό τη μορφή κόνεως, συμπυκνώματος ή έτοιμη για κατανάλωση. Η παιδιατρική σύνθεση περιλαμβάνει, ανά 100 kcal θρεπτικής αξίας, περίπου 8 έως περίπου 16 g υδατάνθρακες (κατά προτίμηση περίπου 9,4 έως περίπου 12,3 g), περίπου 3 έως περίπου 6 g λιπίδια (κατά προτίμηση περίπου 4,7 έως περίπου 5,6 g), περίπου 1,8 έως περίπου 3,3 g πρωτεΐνες (κατά προτίμηση περίπου 2,4 έως περίπου 3,3 g) και ένα βελτιωτικό της ανεκτικότητος περιλαμβάνον περίπου 37 έως περίπου 370 mg (κατά προτίμηση περίπου 74 έως περίπου 222 mg, προτιμότερα περίπου 111 έως περίπου 148 mg) κόμμι ξανθάνης. Η σύνθεση μπορεί επίσης να παρέχεται υπό τη μορφή κόνεως, η περιλαμβάνει ανά 100 g κόνεως, περίπου 30 έως περίπου 90 g υδατάνθρακες (κατά προτίμηση περίπου 48 έως περίπου 59 g), περίπου 15 έως περίπου 30 g λιπίδια (κατά προτίμηση περίπου 20 έως περίπου 30), περίπου 8 έως περίπου 17 g πρωτεΐνη (κατά προτίμηση περίπου 10 έως περίπου 17 g) και περίπου 188 έως περίπου 1880 mg (κατά προτίμηση περίπου 375 έως περίπου 1125 mg, προτιμότερα περίπου 565 έως περίπου 750 mg) κόμμι ξανθάνης. Η σύνθεση κατά προτίμηση περιλαμβάνει περαιτέρω βιταμίνες και ανόργανα και μπορεί να περιλαμβάνει περαιτέρω ένα σταθεροποιητή. Οι μέθοδοι περιλαμβάνουν τη χορήγηση σε έναν παιδιατρικό ασθενή μίας αποτελεσματικής ποσότητος μίας παιδιατρικής συνθέσεως σύμφωνα με την εφεύρεση, όπως περιγράφηκε ανωτέρω.
CY20061100828T 2000-02-04 2006-06-21 Βελτιωμενη παιδιατρικη συνθεση και μεθοδοι για την παροχη τροφης και τη βελτιωση της ανεκτικοτητος CY1108033T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/498,350 US6365218B1 (en) 2000-02-04 2000-02-04 Pediatric formula and methods for providing nutrition and improving tolerance
EP01948924A EP1251750B1 (en) 2000-02-04 2001-01-16 Improved pediatric formula and methods for providing nutrition and improving tolerance

Publications (1)

Publication Number Publication Date
CY1108033T1 true CY1108033T1 (el) 2013-09-04

Family

ID=23980707

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061100828T CY1108033T1 (el) 2000-02-04 2006-06-21 Βελτιωμενη παιδιατρικη συνθεση και μεθοδοι για την παροχη τροφης και τη βελτιωση της ανεκτικοτητος

Country Status (28)

Country Link
US (2) US6365218B1 (el)
EP (1) EP1251750B1 (el)
JP (1) JP2003521501A (el)
KR (1) KR100767202B1 (el)
CN (1) CN1400870A (el)
AT (1) ATE321462T1 (el)
AU (1) AU780438B2 (el)
BG (1) BG107019A (el)
BR (1) BR0106681A (el)
CA (1) CA2396148C (el)
CY (1) CY1108033T1 (el)
CZ (1) CZ20022743A3 (el)
DE (1) DE60118387T2 (el)
DK (1) DK1251750T3 (el)
ES (1) ES2261432T3 (el)
HK (1) HK1050983B (el)
HU (1) HUP0204382A3 (el)
IL (1) IL150326A (el)
MX (1) MXPA02006938A (el)
NO (1) NO20023684L (el)
NZ (1) NZ519695A (el)
PL (1) PL357134A1 (el)
PT (1) PT1251750E (el)
SI (1) SI21018A (el)
SK (1) SK12562002A3 (el)
TR (1) TR200201921T2 (el)
TW (1) TWI241167B (el)
WO (1) WO2001056406A1 (el)

Families Citing this family (146)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6365218B1 (en) * 2000-02-04 2002-04-02 Abbott Laboratories Pediatric formula and methods for providing nutrition and improving tolerance
SE520688C2 (sv) * 2000-04-11 2003-08-12 Bone Support Ab Ett injicerbart ersättningsmaterial för benmineral
SE517168C2 (sv) * 2000-07-17 2002-04-23 Bone Support Ab En komposition för ett injicerbart ersättningsmaterial för benmineral
US6716466B2 (en) * 2001-01-17 2004-04-06 Nestec S.A. Balanced food powder composition
US20040121044A1 (en) * 2001-03-14 2004-06-24 John Tiano Nutritional product with high protein, low carbohydrate content and good physical stability
US6808736B2 (en) * 2001-06-07 2004-10-26 Nestec S.A. Soy hydrolysate based nutritional formulations
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US20060039958A1 (en) * 2003-05-28 2006-02-23 Monosolrx, Llc. Multi-layer films having uniform content
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US20030099753A1 (en) * 2001-11-20 2003-05-29 Yang Baokang Juice based beverage compositions
SE522098C2 (sv) * 2001-12-20 2004-01-13 Bone Support Ab Ett nytt benmineralsubstitut
US8367098B2 (en) 2002-04-30 2013-02-05 The Population Council, Inc. Unique combinations of antimicrobial compositions
US7070825B2 (en) 2002-09-10 2006-07-04 Abbott Laboratories Infant formula
SE0300620D0 (sv) * 2003-03-05 2003-03-05 Bone Support Ab A new bone substitute composition
US20040214791A1 (en) * 2003-04-25 2004-10-28 Nancy Auestad High lactose infant nutrition formula
DE10339180A1 (de) * 2003-08-21 2005-03-24 Deutsche Gelatine-Fabriken Stoess Ag Kollagenhydrolysat
BRPI0412634A (pt) * 2003-09-10 2006-09-26 Unilever Nv composição comestìvel
NO319624B1 (no) * 2003-09-15 2005-09-05 Trouw Internat Bv Fiskefôr for laksefisk i ferskvann og anvendelse av slikt fôr.
SE0302983D0 (sv) * 2003-11-11 2003-11-11 Bone Support Ab Anordning för att förse spongiöst ben med benersättnings- och/eller benförstärkningsmaterial och förfarande i samband därmed
US20050276762A1 (en) * 2004-06-15 2005-12-15 Tapas Das Topical compositions containing 5'-adenosine-diphosphate ribose
SE527528C2 (sv) * 2004-06-22 2006-04-04 Bone Support Ab Anordning för framställning av härdbar massa samt användning av anordningen
DK1799453T3 (da) 2004-09-30 2012-12-17 Monosolrx Llc Flerlagsfilm med ensartet indhold
US20060251634A1 (en) 2005-05-06 2006-11-09 Ho-Jin Kang Method of improving immune function in mammals using lactobacillus strains with certain lipids
WO2006130027A1 (en) * 2005-05-31 2006-12-07 Santos Ma Joyce Bedelia B Aqueous oral liquid vitamin supplements containing stabilized vitamin c and metal ions
US20060286208A1 (en) * 2005-06-01 2006-12-21 Nagendra Rangavajla Methods for producing protein partial hydrolysates and infant formulas containing the same
US7618669B2 (en) * 2005-06-01 2009-11-17 Mead Johnson Nutrition Company Low-lactose partially hydrolyzed infant formula
US7829126B2 (en) 2005-10-26 2010-11-09 Abbott Laboratories Infant formulas containing docosahexaenoic acid and lutein
US20070166354A1 (en) 2005-10-26 2007-07-19 Bridget Barrett-Reis Method of reducing the risk of retinopathy of prematurity in preterm infants
US20070134395A1 (en) * 2005-12-13 2007-06-14 Hodges Everett L Method of reducing manganese in defatted soy isolate
US20070166411A1 (en) * 2005-12-16 2007-07-19 Bristol-Myers Squibb Company Nutritional supplement containing long-chain polyunsaturated fatty acids
US7691547B2 (en) * 2006-03-16 2010-04-06 Microtome Precision, Inc. Reticle containing structures for sensing electric field exposure and a method for its use
US20070281054A1 (en) * 2006-05-31 2007-12-06 Abbott Laboratories Organic powder nutritional formula containing select carbohydrate combinations
EP1867237A1 (en) * 2006-06-15 2007-12-19 Nestec S.A. Hypoallergenic Egg
US20080026105A1 (en) * 2006-07-28 2008-01-31 Bristol-Myers Squibb Company Nutritional formulations containing octenyl succinate anhydride-modified tapioca starch
US8722120B2 (en) * 2006-08-02 2014-05-13 Mead Johnson Nutrition Company Amino acid-based nutritional formulations
CN100463681C (zh) * 2006-10-24 2009-02-25 北京紫竹药业有限公司 一种治疗干眼症的人工泪液
ES2436145T3 (es) 2007-11-07 2013-12-27 Mjn U.S. Holdings Llc Método para disminuir el amargor y mejorar el sabor de leches maternizadas sin proteínas e hidrolizadas
US8329642B1 (en) 2007-11-14 2012-12-11 Gans Eugene H Formula and method to enhance external physiognomy
CN101877972B (zh) * 2007-11-20 2014-07-09 荷兰纽迪希亚公司 处理刺槐豆胶粉
US9131721B2 (en) * 2007-12-04 2015-09-15 Nestec S.A. Gut microbiota in infants
RU2481008C2 (ru) * 2007-12-20 2013-05-10 Абботт Лаборэтриз Композиции питательного порошка и детской питательной смеси (варианты)
US8361534B2 (en) * 2007-12-20 2013-01-29 Abbott Laboratories Stable nutritional powder
US20100068346A1 (en) * 2008-09-16 2010-03-18 Hodges Everett L Infant formula
CN102186360B (zh) * 2008-10-20 2016-08-17 雀巢产品技术援助有限公司 具有抗反流性质的营养组合物
IT1392084B1 (it) * 2008-12-12 2012-02-09 Marzullo Composizione immuno-nutrizionale
JP5710506B2 (ja) † 2009-03-02 2015-04-30 ロケット フレールＲｏｑｕｅｔｔｅ Ｆｒｅｒｅｓ 植物性ミルク造粒粉末、植物性ミルクを生産するための方法、およびその使用
WO2010126353A1 (en) * 2009-04-27 2010-11-04 N.V. Nutricia Pea-based protein mixture and use thereof in a liquid nutritional composition suitable for enteral feeding
TW201112967A (en) 2009-09-16 2011-04-16 Abbott Lab Dryblended nutritional powders
TW201121431A (en) * 2009-12-01 2011-07-01 Abbott Lab Soy protein-based nutritional formula with superior stability
TWI492744B (zh) 2009-12-04 2015-07-21 Abbott Lab 使用類胡蘿蔔素調節早產兒發炎症之方法
CA2785262A1 (en) * 2009-12-22 2011-07-21 Nestec S.A. Nutritional compositions and methods for optimizing dietary acid-base potential
CN102985105B (zh) 2010-01-19 2016-03-09 雅培制药有限公司 包含合生元的营养配方
US9693577B2 (en) 2010-01-29 2017-07-04 Abbott Laboratories Method of preparing a nutritional powder comprising spray dried HMB
US8916217B2 (en) 2010-01-29 2014-12-23 Abbott Laboratories Aseptically packaged nutritional liquids comprising HMB
SG182812A1 (en) 2010-01-29 2012-09-27 Abbott Lab Nutritional emulsions comprising calcium hmb
US9180137B2 (en) 2010-02-09 2015-11-10 Bone Support Ab Preparation of bone cement compositions
TWI526161B (zh) 2010-06-10 2016-03-21 亞培公司 包含鈣ｈｍｂ及可溶性蛋白質之實質上透明營養液
EP2397038A1 (en) 2010-06-21 2011-12-21 Abbott Laboratories Early programming of brain function through soy protein feeding
EP2404507A1 (en) * 2010-07-08 2012-01-11 Nestec S.A. Array of age-tailored nutritional formula with optimum fat content
WO2012009426A1 (en) 2010-07-13 2012-01-19 Abbott Laboratories High tolerance infant formula including hydrolyzed protein
EP2422629A1 (en) 2010-08-23 2012-02-29 Abbott Laboratories Methods for enhancing cognition and/or memory using maltodextrins
ES2548629T3 (es) 2010-08-24 2015-10-19 Abbott Laboratories Productos nutritivos que tienen propiedades organolépticas mejoradas
WO2012027287A1 (en) 2010-08-24 2012-03-01 Abbott Laboratories Nutritional products including pea protein hydrolysates
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
FI123201B (fi) * 2010-10-29 2012-12-14 Valio Oy Maitopohjainen tuote ja valmistusmenetelmä
FR2968895B1 (fr) * 2010-12-17 2013-04-12 United Pharmaceuticals Composition anti-regurgitation et/ou anti-reflux gastro-oesophagien, preparation et utilisations
CA2821935A1 (en) 2010-12-29 2012-07-05 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis, colic, and short bowel syndrome in an infant, toddler, or child
EP2658397A1 (en) * 2010-12-30 2013-11-06 Abbott Laboratories Improved tolerance in a low calorie infant formula
MX2013007693A (es) * 2010-12-30 2013-08-15 Abbott Lab Formula infantil de bajo contenido calorico con atributos fisicos mejorados.
WO2012092083A1 (en) * 2010-12-30 2012-07-05 Abbott Laboratories Improved rate of protein digestion in a low calorie infant formula
DK2658549T3 (da) 2010-12-31 2020-06-29 Abbott Lab Fremgangsmåder til reduktion af incidensen af oxidativt stress under anvendelse af humane mælkeoligosaccharider, vitamin c og anti-inflammatoriske midler
SG10201603856PA (en) 2010-12-31 2016-07-28 Abbott Lab Methods For Decreasing The Incidence Of Necrotizing Enterocolitis In Infants, Toddlers, Or Children Using Human Milk Oligosaccharides
MY166946A (en) 2010-12-31 2018-07-25 Abbott Lab Methods of using human milk oligosaccharides for improving airway respiratory health
US9283240B2 (en) 2010-12-31 2016-03-15 Abbott Laboratories Human milk oligosaccharides for modulating inflammation
US9763970B2 (en) 2010-12-31 2017-09-19 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
SG191393A1 (en) 2010-12-31 2013-08-30 Abbott Lab Neutral human milk oligosaccharides to promote growth of beneficial bacteria
US20120171166A1 (en) 2010-12-31 2012-07-05 Abbott Laboratories Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
US8703737B2 (en) 2010-12-31 2014-04-22 Abbott Laboratories Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
WO2013012989A2 (en) 2011-07-19 2013-01-24 The Trustees Of Columbia University In The City Of New York Method and system for production of hydrogen and carbon monoxide
WO2013016111A1 (en) 2011-07-22 2013-01-31 Abbott Laboratories Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
MX2011007872A (es) 2011-07-26 2013-01-29 Nucitec Sa De Cv Composicion nutrimental para niños que presentan reflujo, colico y/o estreñimiento.
SG2014013478A (en) 2011-08-29 2014-05-29 Abbott Lab Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
SG11201400829VA (en) 2011-09-20 2014-07-30 Abbott Lab Powdered nutritional formulations including spray-dried plant protein
WO2013101516A1 (en) 2011-12-29 2013-07-04 Abbott Laboratories Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using extracted genomic dna
EP2797438A2 (en) 2011-12-29 2014-11-05 Abbott Laboratories Methods for reducing microbial contamination of dryblended powdered nutritional compositions
US10849334B2 (en) 2012-02-01 2020-12-01 Koninklijke Douwe Egberts B.V. Dairy mineral-fortified liquid dairy products and methods for making the dairy mineral-fortified liquid dairy products
US20130196030A1 (en) 2012-02-01 2013-08-01 Anthony William Criezis Dairy Products With Added Dairy Minerals And Methods Of Producing The Same
WO2013133691A1 (en) * 2012-03-09 2013-09-12 N.V. Nutricia Liquid nutritional composition comprising free amino acids
CA2866313C (en) 2012-03-27 2017-11-28 Abbott Laboratories Methods for modulating cell-mediated immunity using human milk oligosaccharides
IN2014DN07437A (el) * 2012-03-30 2015-04-24 Otsuka Pharma Co Ltd
WO2013170189A1 (en) 2012-05-11 2013-11-14 Abbott Laboratories Combination of beta - hydroxy - beta - methylbutyrate and beta - alanine for increasing muscle blood flow
DK2708145T3 (en) 2012-09-14 2016-07-18 Abbott Lab Nutritional Compositions for Use in Methods to Modulate Corticosterone Levels in Psychologically Stressed Individuals
ES2795665T3 (es) 2012-09-14 2020-11-24 Abbott Lab Procedimientos para aumentar la funcionalidad cerebral utilizando 2-fucosil-lactosa
EP2708146A1 (en) 2012-09-17 2014-03-19 Abbott Laboratories, Inc. Nutritional composition for pregnant women with a beneficial glucose and insulin profile
WO2014078544A1 (en) 2012-11-14 2014-05-22 Abbott Laboratories Compositions and methods for improving the long term safety of powdered infant formulas
WO2014099904A1 (en) 2012-12-17 2014-06-26 Abbott Laboratories Methods for enhancing motor function, enhancing functional status and mitigating muscle weakness in a subject
WO2014100022A1 (en) 2012-12-18 2014-06-26 Abbott Laboratories Dietary oligosaccharides to enhance learning and memory
EP2745705A1 (en) 2012-12-18 2014-06-25 Abbott Laboratories Nutritional use of human milk oligosaccharides
MY187609A (en) 2012-12-18 2021-10-04 Abbott Lab Human milk oligosaccharides to ameliorate symptoms of stress
US10624916B2 (en) 2012-12-20 2020-04-21 Abbott Laboratories Nutritional formulations using human milk oligosaccharides for modulating inflammation
EP2745708A1 (en) 2012-12-24 2014-06-25 Abbott Laboratories, Inc. Antidepressant effect of ß-hydroxy-ß-methylbutyrate
PT2958603T (pt) 2013-02-20 2018-06-06 Bone Support Ab Endurecimento melhorado de substituto ósseo endurecível
US20140242216A1 (en) * 2013-02-24 2014-08-28 Mead Johnson Nutrition Company Amino Acid And Protein Hydrolysate Based Formulas With A Stable Emulsion System
MX2015012546A (es) 2013-03-12 2016-06-02 Abbott Lab Composición que comprende un agente multifuncional modificador de la viscosidad.
US20160037815A1 (en) 2013-03-15 2016-02-11 Abbott Laboratories Nutritional compositions including calcium beta-hydroxy-beta-methylbutyrate, casein phosphopeptide, and protein
US20140271979A1 (en) * 2013-03-15 2014-09-18 Mead Johnson Nutrition Company Anti-regurgitation nutritional composition
SG11201507135XA (en) 2013-03-15 2015-10-29 Abbott Lab Methods of maintaining and improving muscle function
FR3005392B1 (fr) * 2013-05-07 2015-09-18 United Pharmaceuticals Composition anti-regurgitation preservant le transit intestinal
US20160136192A1 (en) 2013-06-10 2016-05-19 Abbott Laboratories Methods and compositions for enhancing cognitive performance
WO2015048646A1 (en) 2013-09-30 2015-04-02 Abbott Laboratories Protein powder
SG11201502037QA (en) 2013-10-11 2015-05-28 Abbott Lab Nutritional composition for pregnant women with a beneficial glucose and insulin profile
WO2015077233A1 (en) 2013-11-19 2015-05-28 Abbott Laboratories Methods for preventing or mitigating acute allergic responses using human milk oligosaccharides
EP2888950A1 (en) 2013-12-24 2015-07-01 Abbott Laboratories Methods for treating, preventing, or reducing neuroinflammation or cognitive impairment
WO2015105981A2 (en) 2014-01-09 2015-07-16 Abbott Laboratories Conditional essentiality of hmb
CN106132420A (zh) 2014-04-08 2016-11-16 雅培公司 使用人乳寡糖增强对病原体的粘膜先天免疫反应和/或检测的方法
WO2016061486A1 (en) * 2014-10-16 2016-04-21 Cargill, Incorporated Process for preparing a directly compressible erythritol & uses thereof
CN104489660A (zh) * 2014-12-10 2015-04-08 常州兆阳光能科技有限公司 富硒低糖营养保健液
CN104544092A (zh) * 2015-01-29 2015-04-29 王维义 一种亚麻籽油微囊粉及其制备工艺
WO2016126215A1 (en) * 2015-02-03 2016-08-11 Jirapinyo Pipop Amino acid-based formula and production process thereof
US10617700B1 (en) 2016-02-26 2020-04-14 Michelle Ann Toothman Vitamin supplement compositions with enhanced bioavailability
US11122833B1 (en) 2016-02-26 2021-09-21 Michelle Ann Toothman Infant formulas having vitamin complexes with enhanced bioavailability
US10039805B1 (en) 2016-02-26 2018-08-07 Michelle Ann Toothman Infant formulas having vitamin complexes with enhanced bioavailability
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
US11191737B2 (en) 2016-05-05 2021-12-07 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine compositions
SE542106C2 (en) * 2016-08-26 2020-02-25 Atif M Dabdoub Dietary macro/micronutritional supplement for patients undergoing kidney dialysis
WO2018050705A1 (en) * 2016-09-13 2018-03-22 Nestec S.A. Infant formula for cow's milk protein allergic infants
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof
US20220192237A1 (en) * 2019-05-02 2022-06-23 Nuflower Foods And Nutrition Private Limited Ready to use food compositions and a method of making the same
SG11202113058VA (en) 2019-06-07 2021-12-30 Abbott Lab Nutritional ingredient with flow and antifoam properties
EP4132560A1 (en) 2020-04-06 2023-02-15 Abbott Laboratories Nutritional formulations for modulating respiratory-induced cytokines
KR102594730B1 (ko) * 2020-09-21 2023-10-26 숙명여자대학교산학협력단 농축 유청 단백질 및 검류 혼합물로 이루어진 점도증진용 조성물
WO2022177965A1 (en) 2021-02-16 2022-08-25 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides and bovine immunoglobulin
WO2022226311A1 (en) 2021-04-23 2022-10-27 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides and a designed lipid component for improving lung function
WO2022266058A1 (en) 2021-06-14 2022-12-22 Abbott Laboratories Methods and compositions for treating gas
WO2023159093A1 (en) 2022-02-16 2023-08-24 Abbott Laboratories Nutritional compositions comprising human milk oligosaccharides and bovine immunoglobulin
WO2024064327A1 (en) 2022-09-22 2024-03-28 Abbott Laboratories Human milk oligosaccharides for enhancing blood-brain barrier function
WO2024089059A1 (en) 2022-10-25 2024-05-02 N.V. Nutricia Thickened formula for allergic infants
WO2024089060A1 (en) * 2022-10-25 2024-05-02 N.V. Nutricia Antiregurgitation formula

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4282262A (en) 1980-03-04 1981-08-04 General Mills, Inc. Dairy based mixes for frozen desserts and method of preparation
EP0045158A1 (en) 1980-07-17 1982-02-03 Merck & Co. Inc. Process for thickening and stabilizing oil in water emulsions containing milk solids and emulsion stabilizer for use therein
US4670268A (en) 1985-01-29 1987-06-02 Abbott Laboratories Enteral nutritional hypoallergenic formula
DD294404A5 (de) * 1989-09-18 1991-10-02 Akademie Der Wissenschaften,De Verfahren zur herstellung von trockenmischungen fuer die zubereitung von fett-in-wasser-emulsionen fuer lebensmittelzwecke
US5171602A (en) 1990-06-13 1992-12-15 Kraft General Foods, Inc. Non-fat frozen dairy product
CH681343A5 (el) 1990-10-26 1993-03-15 Nestle Sa
US5256436A (en) 1992-05-14 1993-10-26 The Coca-Cola Company Ready to serve frozen dessert for soft serve dispensing
FR2699370B1 (fr) * 1992-12-17 1995-01-13 Cedilac Sa Procédé pour la fabrication d'un lait infantile liquide prêt à l'emploi longue conservation et anti-régurgitation, et lait ainsi obtenu.
US5472952A (en) 1993-03-18 1995-12-05 Bristol-Myers Squibb Company Partially hydrolyzed pectin in nutritional compositions
US5376396A (en) 1993-04-27 1994-12-27 Merck & Co., Inc. Beverage stabilizing system and process thereof
JP3510376B2 (ja) 1995-03-16 2004-03-29 太陽化学株式会社 安定な乳飲料の製造法
US5597595A (en) 1995-04-07 1997-01-28 Abbott Laboratories Low pH beverage fortified with calcium and vitamin D
US5817351A (en) 1995-04-07 1998-10-06 Abbott Laboratories Calcium fortified low pH beverage
US5609897A (en) 1995-04-07 1997-03-11 Abbott Laboratories Powdered beverage concentrate or additive fortified with calcium and vitamin D
US6099871A (en) * 1995-06-01 2000-08-08 Bristol-Myers Squibb Company Anti-regurgitation infant formula
US5827544A (en) * 1995-10-10 1998-10-27 The Arab Pharmaceutical Manufacturing Co. Ltd. Different way of management of neonatal hyperbilirubinemia
CN1086282C (zh) 1995-12-15 2002-06-19 普罗克特和甘保尔公司 含有多磷酸盐防腐剂体系和少量黄原胶的,具有稳定的风味乳浊液/混浊乳浊液的饮料
US5681600A (en) 1995-12-18 1997-10-28 Abbott Laboratories Stabilization of liquid nutritional products and method of making
BR9708545A (pt) 1996-04-09 1999-08-03 Du Pont Produto de proteína de soja método para a fabricação de um produto de proteína de soja produto substituinte do leite formulação para crianças pó ou líquido de bebida nutritivo pasta de queijo produto de presunto bologna produto de iogurte e sobremesa congelada
US6365218B1 (en) * 2000-02-04 2002-04-02 Abbott Laboratories Pediatric formula and methods for providing nutrition and improving tolerance

Also Published As

Publication number Publication date
BR0106681A (pt) 2002-04-30
EP1251750A1 (en) 2002-10-30
ATE321462T1 (de) 2006-04-15
HK1050983B (zh) 2006-10-27
CA2396148C (en) 2011-09-06
PT1251750E (pt) 2006-08-31
MXPA02006938A (es) 2003-01-28
DE60118387T2 (de) 2006-12-07
HUP0204382A2 (hu) 2003-04-28
DE60118387D1 (de) 2006-05-18
HUP0204382A3 (en) 2004-07-28
JP2003521501A (ja) 2003-07-15
SI21018A (sl) 2003-04-30
US6365218B1 (en) 2002-04-02
SK12562002A3 (sk) 2002-12-03
KR20020075787A (ko) 2002-10-05
NO20023684L (no) 2002-10-02
HK1050983A1 (en) 2003-07-18
TWI241167B (en) 2005-10-11
IL150326A (en) 2005-06-19
US20020176911A1 (en) 2002-11-28
PL357134A1 (en) 2004-07-12
TR200201921T2 (tr) 2003-01-21
CN1400870A (zh) 2003-03-05
DK1251750T3 (da) 2006-08-07
BG107019A (bg) 2003-04-30
AU2949001A (en) 2001-08-14
KR100767202B1 (ko) 2007-10-17
AU780438B2 (en) 2005-03-24
EP1251750B1 (en) 2006-03-29
US6589576B2 (en) 2003-07-08
NZ519695A (en) 2004-10-29
CZ20022743A3 (cs) 2002-11-13
CA2396148A1 (en) 2001-08-09
ES2261432T3 (es) 2006-11-16
IL150326A0 (en) 2002-12-01
NO20023684D0 (no) 2002-08-02
WO2001056406A1 (en) 2001-08-09

Similar Documents

Publication Publication Date Title
CY1108033T1 (el) Βελτιωμενη παιδιατρικη συνθεση και μεθοδοι για την παροχη τροφης και τη βελτιωση της ανεκτικοτητος
DK1001685T3 (da) Næringsmiddelsammensætning indeholdende methionin
PT1056357E (pt) Composicao nutricional altamente calorica
CY1105000T1 (el) Χρηση της σπινοσαδης ή μιας συνθεσεως περιεχουσης σπινοσαδη
MX9504034A (es) Formas de administracion medicamentosas que contienen acido tioctico, o sales solidas del acido tioctico de liberacion y biodisponibilidad mejoradas.
CY1108138T1 (el) Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι
TR200101633T2 (tr) Farmasötik bileşim
CY1107349T1 (el) Αλφα-κετογλουταρικα ενεργα συστατικα και σκευασματα που τα περιεχουν
BR0308713A (pt) Co-esférula de dha e alecrim, e métodos de uso
HUP0002198A2 (hu) L-Karnitin- vagy alkanoil-L-karnitin-magnézium-fumarátot tartalmazó orálisan beadható szilárd készítmények
PT971879E (pt) Composicoes solidas adequadas para administracao oral compreendendo l-carnitino e alcanoil.l.carnitino tartarato de magnesio
AU2003290031A1 (en) Method of improvement of blood circulation
IL131956A0 (en) Solid compositions suitable for oral administration comprising non hygroscopic salts of l-carnitine and alkanoyl-l-carnitine with 2-aminoethanesulfonic acid
BR9808908A (pt) Composições sólidas adequadas para administração oral que compreendem l-carnitina ou tartarato de alcanoil-l-carnitina colina
HK1036203A1 (en) Food supplements comprising lipoic acid and creatine and methods for their use
EA199700019A1 (ru) Способ увеличения прироста цыплят
MX9708044A (es) Regulador de tension para animales.